Log in to save to my catalogue

Artificially cloaked viral nanovaccine for cancer immunotherapy

Artificially cloaked viral nanovaccine for cancer immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b72055f0b5e4f6496735a1c2b068f78

Artificially cloaked viral nanovaccine for cancer immunotherapy

About this item

Full title

Artificially cloaked viral nanovaccine for cancer immunotherapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-12, Vol.10 (1), p.5747-13, Article 5747

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Virus-based cancer vaccines are nowadays considered an interesting approach in the field of cancer immunotherapy, despite the observation that the majority of the immune responses they elicit are against the virus and not against the tumor. In contrast, targeting tumor associated antigens is effective, however the identification of these antigens r...

Alternative Titles

Full title

Artificially cloaked viral nanovaccine for cancer immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2b72055f0b5e4f6496735a1c2b068f78

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b72055f0b5e4f6496735a1c2b068f78

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-13744-8

How to access this item